-
oa Erratum
- Source: Current Medicinal Chemistry, Volume 14, Issue 16, Jul 2007, p. 1805 - 1805
-
- 01 Jul 2007
Abstract
The figure on the cover was published in Curr. Med. Chem., Volume 13, Number 2, 2006. On the next page of this issue, Osman Guner and Omoshile Clement, from Accelrys, 9685 Scranton Road, San Diego, CA 92121, USA, and Yasuhisa Kurogi, from Cambridge Isotope Laboratories, Inc., 50 Frontage Road, Andover, MA 01810, USA, fraudulently assigned to themselves the authorship of this figure. However, the real authors are Albert Palomer, Francesc Cabre, Jaume Pascual, Lluisa Garcia, and David Mauleon, from the R & D Department, Laboratorios Menarini S. A., Alfonso XII 587, 08918 Badalona, Spain, and Joaquin Campos, Maria A. Trujillo, Antonio Entrena, Miguel A. Gallo, and Antonio Espinosa, from the Departamento de Quimica Organica, Facultad de Farmacia, Universidad de Granada, Campus de Cartuja s/n, 18071 Granada, Spain. The cover slide shows the catalyst-generated pharmacophore model for the COX-2 inhibition aligned with the proteinbound structure of SC-558 (green), and a novel computer-designed COX-2 lead (red). The figure is reprinted with permission from the J. Med. Chem., 2002, 45, 1402-1411. Copyright (2007) American Chemical Society.